Teradyne, INC
Market Movers (8-K)
NASDAQ
Teradyne announced record second quarter 2026 revenue of $1,329 million, a 104% increase year-over-year, driven by strong performance across its Semiconductor Test, Product Test, and Robotics segments.
Better than expected
NASDAQ
Teradyne, Inc. held its 2026 annual meeting of shareholders, where directors were re-elected and executive compensation was approved.
NASDAQ
Teradyne announced record first quarter 2026 revenue of $1.282 billion and strong EPS, significantly exceeding guidance due to robust AI-related demand.
Better than expected
NASDAQ
Teradyne, Inc. reported fourth quarter and full year 2025 financial results, surpassing Q4 guidance with revenue of $1.083 billion driven by strong AI-related demand.
Better than expected
NASDAQ
Teradyne, Inc. reported third-quarter 2025 revenue and earnings at the high-end of its guidance, driven by strong Semiconductor Test performance and robust AI-related demand, with a significant increase expected in Q4.
Better than expected
NASDAQ
Teradyne, a leading automated test equipment and robotics provider, announced Michelle Turner will succeed Sanjay Mehta as Chief Financial Officer, effective November 3, 2025.
Quarterly Earnings (10-Q)
NASDAQ
Teradyne Inc. announced robust Q2 2026 financial results, with revenues soaring to $1.33 billion, largely propelled by significant demand in AI-driven semiconductor testing.
Better than expected
NASDAQ
Teradyne reported strong Q1 2026 results with record Semiconductor Test revenue exceeding $1 billion, fueled by AI-related demand.
Better than expected
NASDAQ
Teradyne reports mixed Q3 results with strong Semiconductor Test revenue driven by AI demand, while Robotics revenue declines and executive changes are announced.
Worse than expected
Capital raise
NASDAQ
Teradyne, a leading automated test equipment and robotics provider, reported a significant year-over-year decline in second-quarter revenue and net income, primarily due to lower memory sales in Semiconductor Test and ongoing macroeconomic challenges impacting its Robotics segment, though it anticipates strengthening demand in Semiconductor Test for the second half of 2025.
Worse than expected
NASDAQ
Teradyne's Q1 2025 results show revenue growth driven by the Semiconductor Test segment, despite a decline in Robotics revenue.
Better than expected
NASDAQ
Teradyne's Q3 2024 results show growth in Semiconductor Test driven by compute and memory, offsetting declines in System Test and Wireless Test, while Robotics revenue aligns with forecasts.
Better than expected
Annual Reports (10-K)
NASDAQ
Teradyne's 2025 annual report reveals significant revenue growth in Semiconductor Test driven by AI demand, strategic acquisitions, and a new joint venture, despite a decline in Robotics revenue.
Better than expected
NASDAQ
Teradyne's 2024 10-K filing reveals a mixed performance, with strong growth in the Semiconductor Test business offsetting a decline in Robotics revenue due to a weak industrial automation market.
Delay expected
NASDAQ
Teradyne's 10-K filing outlines the details of its common stock, voting rights, dividend entitlements, and various anti-takeover provisions.
Insider Trading (Form 4)
NASDAQ
Form 4: Teradyne Director Sells Shares
Mercedes Johnson, a Director of Teradyne, Inc, sold 166 shares of common stock on August 3, 2026 for $358.15 per share.
NASDAQ
Form 4: Teradyne CEO Sells Shares
Gregory Stephen Smith, President and CEO and a Director of Teradyne, Inc, sold 4,000 shares of common stock on July 15, 2026 for $356.31 per share.
NASDAQ
Form 4: Teradyne Director Sells Shares
Marilyn Matz, a Director of Teradyne, Inc, sold 1,200 shares of common stock on July 15, 2026 for $356.31 per share.
NASDAQ
Mercedes Johnson, a Director at Teradyne, Inc., reported a sale of common stock under a Rule 10b5-1 trading plan.
NASDAQ
Teradyne Director Paul J. Tufano acquired deferred stock units valued at $0 on June 25, 2026, increasing his beneficial ownership.
NASDAQ
Teradyne, Inc. reports a Form 4 filing detailing a director's acquisition of deferred stock units.
Proxy Statements (Def-14A)
NASDAQ
Teradyne's 2026 Proxy Statement reveals robust 2025 financial performance driven by AI demand, strategic executive changes, and enhanced corporate governance.
Better than expected
NASDAQ
Teradyne's upcoming annual meeting on May 9, 2025, will address key proposals including the election of directors, executive compensation, and the ratification of PricewaterhouseCoopers LLP as the company's auditor.
NASDAQ
Teradyne's 2025 proxy statement outlines key proposals for shareholder vote, including director elections, executive compensation, and an amendment to the equity incentive plan.
Worse than expected
NASDAQ
DEFA14A: Teradyne, Inc. Sets Date for 2024 Annual Meeting, Outlines Key Proposals for Shareholder Vote
Teradyne, Inc. announces its 2024 Annual Meeting of Shareholders to be held on May 9, 2024, outlining proposals for director elections, executive compensation, and amendments to the company's Articles of Organization.
NASDAQ
Teradyne's proxy statement details proposals for the upcoming annual meeting, including director elections, executive compensation advisory vote, and a key amendment to lower voting requirements for significant corporate actions.
Worse than expected
Schedule 13G - Passive Investments
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 10.1% of Teradyne Inc.'s common stock as of May 31, 2026.
NASDAQ
Vanguard Portfolio Management has reported beneficial ownership of 5.5% of Teradyne Inc.'s common stock as of March 31, 2026.
NASDAQ
Vanguard Capital Management has reported a beneficial ownership of 7.49% in Teradyne Inc. common stock as of March 31, 2026.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Teradyne Inc. following an internal realignment.
NASDAQ
The Vanguard Group has disclosed an increased beneficial ownership of 13.07% in Teradyne Inc., holding over 20.9 million shares as of June 30, 2025.
NASDAQ
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.9% in Teradyne Inc.'s common stock as of March 31, 2025.